Generation of airway basal stem cells from human pluripotent stem cells
US11401510B2 · kind B2 · utility
0Cited by
0References
26Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 19, 2021 |
| Grant date | Aug 2, 2022 |
| Priority date | — |
| Expiry date | Feb 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein is a method of generating in-vitro differentiated airway basal cells and compositions thereof. Also described herein is a method of treating a pulmonary disease comprising administering the in-vitro differentiated airway basal cells and compositions thereof. In another aspect, described herein is a disease model comprising patient-derived or genetically modified in-vitro differentiated airway basal cells and compositions thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.